LRK-A

N/A

Report date: 2024/04/22 17:41:26
NMEFirst In Class

Base Information

Drug NameLRK-A
Drug Alias NameLRK-A
ClassificationOther
Mechanisms of ActionPhosphatidylinositol 5-phosphate 4-kinase γ degraders
TargetsPhosphatidylinositol 5-phosphate 4-kinase γ
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLarkspur Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLarkspur Biosciences Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A